Research integrity is at the heart of Purely Academic, a staged reading to be performed by University of Queensland staff at the Geoffrey Rush Drama Studio next month.

24 October 2016

The University of Queensland is again Australia’s highest-ranking institution on the Nature Index, further strengthening its global reputation as a top-tier research organisation.

21 April 2016

University of Queensland pain treatment researchers have discovered thousands of new peptide toxins hidden deep within the venom of just one type of Queensland cone snail.

7 July 2015
It's an exciting time in medical discovery, says UQ Deputy Vice-Chancellor (Research) Professor Anton MIddelberg

The National Health and Medical Research Council has awarded six new Research Fellowships at The University of Queensland, and extended funding on another four.

2 September 2014
Professor Alewood from UQ's IMB has developed a molecule that showed significant potential in alleviating abdominal pain.

Australian researchers have found a key to treating chronic abdominal pain may lie in a hormone that induces labour and encourages social bonding.

31 January 2014

Australian scientists are working with industry to develop a spider venom extract for treating chronic pain.

17 February 2012

Fifty two leading researchers from The University of Queensland were honoured on Sunday as leaders in their diverse fields of discovery at the inaugural Q-Index Awards.

17 May 2011

Groundbreaking research into nanotechnology and advanced polymers will be accelerated with $3.6 million in infrastructure funding awarded to The University of Queensland (UQ) today.

1 December 2010

A venom component from the Taipan, the world’s deadliest snake, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.

21 February 2005

A venom compound from the world’s deadliest snake, the Taipan, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.

29 November 2004

The world`s leading experts on developing drugs from the venom of poisonous creatures, will descend on Heron Island on Queensland’s Great Barrier Reef from July 14-19.

12 June 2002

The University of Queensland has attracted the largest Australian Research Council (ARC) Discovery grant for a project investigating potential new drug therapies derived from the venom of marine snails.

24 September 2001

For the first time in Australia, a University of Queensland molecular biologist has analysed at a molecular level the toxins of funnel-web venom from a spider responsible for the near death of its victim.

18 June 2001

Young University of Queensland scientist Dr Peter Cassidy has invested six years of his life in building frameworks for new drugs.

25 October 2000

Xenome Ltd Company targets new generation pharmaceuticals from the venom of Australia's unique fauna Queensland's rapidly emerging biotechnology industry will be enhanced with the establishment of Xenome Limited, an IMB spin-off company...

9 March 2000

The poison chalice of a humble marine snail is fast becoming the Holy Grail of pain relieving drugs.

6 October 1999

Queensland Governor Major General Peter Arnison today will visit research laboratories associated with the University of Queensland's planned $100m Institute for Molecular Bioscience at St Lucia at 3pm.

3 August 1999

University of Queensland researchers have attracted the top two Australian Research Council (ARC) equipment grants to Queensland for 1999.

15 March 1999

The University of Queensland's Centre for Drug Design and Development has launched three spin-off biotechnology companies to further develop intellectual property and commercialise the results of its research.

26 February 1999

The University of Queensland's Centre for Drug Design and Development (3D) has experienced one of its most successful years in funding grants

24 February 1999